These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 36549115)

  • 21. Imidazopyridine, a promising scaffold with potential medicinal applications and structural activity relationship (SAR): recent advances.
    Khatun S; Singh A; Bader GN; Sofi FA
    J Biomol Struct Dyn; 2022; 40(24):14279-14302. PubMed ID: 34779710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evodiamine: A Privileged Structure with Broad-ranging Biological Activities.
    Li D; Li Y; Jiang X; Liu W; Zhao Q
    Mini Rev Med Chem; 2022; 22(21):2680-2701. PubMed ID: 35379148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Synthesis, Structural Modification and Mode of Anticancer Action of Evodiamine: A Review.
    Fan M; Yao L
    Recent Pat Anticancer Drug Discov; 2022; 17(3):284-296. PubMed ID: 34939550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A promising antitumor activity of evodiamine incorporated in hydroxypropyl-β-cyclodextrin: pro-apoptotic activity in human hepatoma HepG2 cells.
    Qiu C; Gao LN; Yan K; Cui YL; Zhang Y
    Chem Cent J; 2016; 10():46. PubMed ID: 27458481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-activity Relationship Studies of New Marine Anticancer Agents and their Synthetic Analogues.
    Fedorov SN; Stonik VA; Honecker F; Dyshlovoy SA
    Curr Med Chem; 2017; 24(42):4779-4799. PubMed ID: 27903218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthetic and natural coumarins as potent anticonvulsant agents: A review with structure-activity relationship.
    Keri RS; Budagumpi S; Balappa Somappa S
    J Clin Pharm Ther; 2022 Jul; 47(7):915-931. PubMed ID: 35288962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of JNK contributes to evodiamine-induced apoptosis and G2/M arrest in human colorectal carcinoma cells: a structure-activity study of evodiamine.
    Chien CC; Wu MS; Shen SC; Ko CH; Chen CH; Yang LL; Chen YC
    PLoS One; 2014; 9(6):e99729. PubMed ID: 24959718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imidazo[1,2-b]pyridazine as privileged scaffold in medicinal chemistry: An extensive review.
    Garrido A; Vera G; Delaye PO; Enguehard-Gueiffier C
    Eur J Med Chem; 2021 Dec; 226():113867. PubMed ID: 34607244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of natural product anticancer agents from biodiverse organisms.
    Kinghorn AD; Chin YW; Swanson SM
    Curr Opin Drug Discov Devel; 2009 Mar; 12(2):189-96. PubMed ID: 19333864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Progress in research of the structural optimization of natural product-like Garcinia caged xanthones].
    Wang YY; Zhang XJ; Yang YR; Sun HP; You QD
    Yao Xue Xue Bao; 2014 Mar; 49(3):293-302. PubMed ID: 24961098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioactive pyrrole-based compounds with target selectivity.
    Li Petri G; Spanò V; Spatola R; Holl R; Raimondi MV; Barraja P; Montalbano A
    Eur J Med Chem; 2020 Dec; 208():112783. PubMed ID: 32916311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Marine Natural Products as Models to Circumvent Multidrug Resistance.
    Long S; Sousa E; Kijjoa A; Pinto MM
    Molecules; 2016 Jul; 21(7):. PubMed ID: 27399665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolution in medicinal chemistry of ursolic acid derivatives as anticancer agents.
    Chen H; Gao Y; Wang A; Zhou X; Zheng Y; Zhou J
    Eur J Med Chem; 2015 Mar; 92():648-55. PubMed ID: 25617694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecules of natural origin, semi-synthesis and synthesis with anti-inflammatory and anticancer utilities.
    Lourenço AM; Ferreira LM; Branco PS
    Curr Pharm Des; 2012; 18(26):3979-4046. PubMed ID: 22632756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current developments of coumarin-based anti-cancer agents in medicinal chemistry.
    Emami S; Dadashpour S
    Eur J Med Chem; 2015 Sep; 102():611-30. PubMed ID: 26318068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Marine-Derived Natural Lead Compound Disulfide-Linked Dimer Psammaplin A: Biological Activity and Structural Modification.
    Jing Q; Hu X; Ma Y; Mu J; Liu W; Xu F; Li Z; Bai J; Hua H; Li D
    Mar Drugs; 2019 Jun; 17(7):. PubMed ID: 31252563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Berberine Derivatives with Different Pharmacological Activities via Structural Modifications.
    Xiao D; Liu Z; Zhang S; Zhou M; He F; Zou M; Peng J; Xie X; Liu Y; Peng D
    Mini Rev Med Chem; 2018; 18(17):1424-1441. PubMed ID: 28325147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolution in medicinal chemistry of E-ring-modified Camptothecin analogs as anticancer agents.
    Huang Q; Wang L; Lu W
    Eur J Med Chem; 2013 May; 63():746-57. PubMed ID: 23578545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BMP9 mediates the anticancer activity of evodiamine through HIF‑1α/p53 in human colon cancer cells.
    Li FS; Huang J; Cui MZ; Zeng JR; Li PP; Li L; Deng Y; Hu Y; He BC; Shu DZ
    Oncol Rep; 2020 Feb; 43(2):415-426. PubMed ID: 31894286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evodiamine: A review of its pharmacology, toxicity, pharmacokinetics and preparation researches.
    Sun Q; Xie L; Song J; Li X
    J Ethnopharmacol; 2020 Nov; 262():113164. PubMed ID: 32738391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.